Toggle navigation
Home
Search
Services
Blog
Contact
About
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R.
Sts Biopolymers, Inc., Henrietta, NY, United States
Search 16 grants from Michael Violante
Search grants from Sts Biopolymers, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Multiplexed detection and imaging of protein phosphorylation based on soluble nanopolymers
Micronutrient Malnutrition and EBV Persistence in Children
Tgf-BETA1, Renal Disease and Hypertension
Treatment Research Validation and Extension Program
Immunopathology of Graft-vs-Host Disease
Recently added grants:
Understanding the Mechanism and Preventing the Unique Neuropathology of Arginase Deficiency
Investigation of Partial Electrical Nerve Block for Autonomic Regulation
Cytochrome P450-mediated drug interactions at the human blood-brain barrier
Clinical Translation of Near Infrared Nerve-Specific Fluorophores for Nerve-sparing Prostatectomy
Sensitizing Colorectal Cancer to Checkpoint Inhibitors by WNT Pathway Suppression
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
2R44CA036615-02A1
Application #
3506361
Study Section
Experimental Therapeutics Subcommittee 2 (ET)
Project Start
1986-09-30
Project End
1988-09-29
Budget Start
1986-09-30
Budget End
1987-09-29
Support Year
2
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Sts Biopolymers, Inc.
Department
Type
DUNS #
City
Henrietta
State
NY
Country
United States
Zip Code
14467
Related projects
NIH 1987
R44 CA
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R. / Sts Biopolymers, Inc.
NIH 1986
R44 CA
Insoluble Antineoplastics Paricles for IV Injection
Violante, Michael R. / Sts Biopolymers, Inc.
Comments
Be the first to comment on Michael Violante's grant